Skip to content
2000
Volume 21, Issue 5
  • ISSN: 1573-398X
  • E-ISSN: 1875-6387

Abstract

Long COVID, or post-COVID syndrome, has emerged as a significant public health challenge, leaving countless individuals with lingering symptoms such as fatigue, breathlessness, and neuropsychiatric issues. Recent evidence suggests a potential role for Vitamin D in alleviating these symptoms, given its anti-inflammatory, immunomodulatory, and neuroprotective properties. Vitamin D’s ability to modulate cytokine storms, enhance antiviral defenses, and support tissue repair highlights its potential for addressing the complex, multi-system effects of Long COVID. This narrative review examines the link between Vitamin D deficiency and the risk of developing Long COVID or experiencing severe COVID-19 (Coronavirus disease 2019) outcomes while also exploring the effectiveness of Vitamin D supplementation in reducing symptom severity and duration in affected individuals. Findings from several observational studies and clinical trials reached varying conclusions. While some studies link lower Vitamin D levels to an increased risk or severity of Long COVID, others report no significant correlation. Furthermore, current clinical trials investigating supplementation indicate potential benefits, including reduced disease severity, lower mortality rates, and improved recovery outcomes, particularly in individuals with pre-existing deficiencies. However, inconsistencies in the structure of clinical trials drive a need for further standardized, large-scale clinical trials to better define Vitamin D’s role in the prevention and management of Long COVID. Vitamin D represents a promising avenue for mitigating the long-term impacts of COVID-19. While current evidence is inconclusive, its safety, affordability, and potential efficacy warrant its consideration in global health strategies aimed at supporting recovery from this complex syndrome.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/crmr/10.2174/011573398X377824250604041213
2025-06-10
2026-01-05

  • From This Site

    /content/journals/crmr/10.2174/011573398X377824250604041213
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. DavisH.E. McCorkellL. VogelJ.M. TopolE.J. Long COVID: Major findings, mechanisms and recommendations.Nat. Rev. Microbiol.202321313314610.1038/s41579‑022‑00846‑236639608
     [Google Scholar]
  2. Office for National Statistics The prevalence of long COVID symptoms and COVID-19 complications.2020Available from: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications
  3. SuY. YuanD. ChenD.G. NgR.H. WangK. ChoiJ. LiS. HongS. ZhangR. XieJ. KornilovS.A. ScherlerK. Pavlovitch-BedzykA.J. DongS. LaustedC. LeeI. FallenS. DaiC.L. BaloniP. SmithB. DuvvuriV.R. AndersonK.G. LiJ. YangF. DuncombeC.J. McCullochD.J. RostomilyC. TroischP. ZhouJ. MackayS. DeGottardiQ. MayD.H. TaniguchiR. GittelmanR.M. KlingerM. SnyderT.M. RoperR. WojciechowskaG. MurrayK. EdmarkR. EvansS. JonesL. ZhouY. RowenL. LiuR. ChourW. AlgrenH.A. BerringtonW.R. WallickJ.A. CochranR.A. MicikasM.E. WrinT. PetropoulosC.J. ColeH.R. FischerT.D. WeiW. HoonD.S.B. PriceN.D. SubramanianN. HillJ.A. HadlockJ. MagisA.T. RibasA. LanierL.L. BoydS.D. BluestoneJ.A. ChuH. HoodL. GottardoR. GreenbergP.D. DavisM.M. GoldmanJ.D. HeathJ.R. ISB-Swedish COVID-19 Biobanking Unit Multiple early factors anticipate post-acute COVID-19 sequelae.Cell20221855881895.e2010.1016/j.cell.2022.01.01435216672
     [Google Scholar]
  4. LogueJ.K. FrankoN.M. McCullochD.J. McDonaldD. MagedsonA. WolfC.R. ChuH.Y. Sequelae in adults at 6 months after COVID-19 infection.JAMA Netw. Open202142e21083010.1001/jamanetworkopen.2021.083033606031
     [Google Scholar]
  5. HikmetR.G. WejseC. AgergaardJ. Effect of vitamin D in long COVID patients.Int. J. Environ. Res. Public Health20232022705810.3390/ijerph2022705837998290
     [Google Scholar]
  6. KocH.C. XiaoJ. LiuW. LiY. ChenG. Long COVID and its Management.Int. J. Biol. Sci.202218124768478010.7150/ijbs.7505635874958
     [Google Scholar]
  7. WangF. KreamR.M. StefanoG.B. Long-term respiratory and neurological sequelae of COVID-19.Med. Sci. Monit.202026e92899610.12659/MSM.92899633177481
     [Google Scholar]
  8. MarshallM. The lasting misery of coronavirus long-haulers.Nature2020585782533934110.1038/d41586‑020‑02598‑632929257
     [Google Scholar]
  9. ChenT.B. ChangC.M. YangC.C. TsaiI.J. WeiC.Y. YangH.W. YangC.P. Neuroimmunological effect of vitamin D on neuropsychiatric long COVID syndrome: A review.Nutrients20231517380210.3390/nu1517380237686834
     [Google Scholar]
  10. PuntmannV.O. CarerjM.L. WietersI. FahimM. ArendtC. HoffmannJ. ShchendryginaA. EscherF. Vasa-NicoteraM. ZeiherA.M. VehreschildM. NagelE. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19).JAMA Cardiol.20205111265127310.1001/jamacardio.2020.355732730619
     [Google Scholar]
  11. VarikasuvuS.R. ThangappazhamB. VykuntaA. DugginaP. ManneM. RajH. AlooriS. COVID-19 and vitamin D (Co-VIVID study): A systematic review and meta- analysis of randomized controlled trials.Expert Rev. Anti Infect. Ther.202220690791310.1080/14787210.2022.203521735086394
     [Google Scholar]
  12. HosseiniB. El AbdA. DucharmeF.M. Effects of vitamin D supplementation on COVID-19 related outcomes: A systematic review and meta-analysis.Nutrients20221410213410.3390/nu1410213435631275
     [Google Scholar]
  13. PetrelliF. LucianiA. PeregoG. DogniniG. ColombelliP.L. GhidiniA. Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies.J. Steroid Biochem. Mol. Biol.202121110588310.1016/j.jsbmb.2021.10588333775818
     [Google Scholar]
  14. KayaM.O. PamukçuE. YakarB. The role of vitamin D deficiency on COVID-19: A systematic review and meta-analysis of observational studies.Epidemiol. Health202143e202107410.4178/epih.e202107434607398
     [Google Scholar]
  15. TeshomeA. AdaneA. GirmaB. MekonnenZ.A. The impact of vitamin D level on COVID-19 infection: Systematic review and meta-analysis.Front. Public Health2021962455910.3389/fpubh.2021.62455933748066
     [Google Scholar]
  16. BilezikianJ.P. BinkleyN. De LucaH.F. FassioA. FormentiA.M. El-Hajj FuleihanG. HeijboerA.C. GiustinaA. Consensus and controversial aspects of vitamin D and COVID-19.J. Clin. Endocrinol. Metab.202310851034104210.1210/clinem/dgac71936477486
     [Google Scholar]
  17. NairR. MaseehA. Vitamin D: The “sunshine” vitamin.J. Pharmacol. Pharmacother.20123211812610.4103/0976‑500X9550622629085
     [Google Scholar]
  18. MoukayedM. GrantW.B. Linking the metabolic syndrome and obesity with vitamin D status: Risks and opportunities for improving cardiometabolic health and well-being.Diabetes Metab. Syndr. Obes.2019121437144710.2147/DMSO.S17693331496777
     [Google Scholar]
  19. GreillerC. MartineauA. Modulation of the immune response to respiratory viruses by vitamin D.Nutrients2015764240427010.3390/nu706424026035247
     [Google Scholar]
  20. YukJ.M. ShinD.M. LeeH.M. YangC.S. JinH.S. KimK.K. LeeZ.W. LeeS.H. KimJ.M. JoE.K. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin.Cell Host Microbe20096323124310.1016/j.chom.2009.08.00419748465
     [Google Scholar]
  21. KimJ. YangY.L. JangS.H. JangY.S. Human β-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity.Virol. J.201815112410.1186/s12985‑018‑1035‑230089512
     [Google Scholar]
  22. GanzT. Hepcidin—A peptide hormone at the interface of innate immunity and iron metabolism.Antimicrobial peptides and human disease.1st ed ShaferW.M. BerlinSpringer200618319810.1007/3‑540‑29916‑5_7
     [Google Scholar]
  23. BacchettaJ. ZaritskyJ.J. SeaJ.L. ChunR.F. LisseT.S. ZavalaK. NayakA. Wesseling-PerryK. WestermanM. HollisB.W. SaluskyI.B. HewisonM. Suppression of iron-regulatory hepcidin by vitamin D.J. Am. Soc. Nephrol.201425356457210.1681/ASN.201304035524204002
     [Google Scholar]
  24. JangW. KimH.J. LiH. JoK.D. LeeM.K. SongS.H. YangH.O. 1,25-Dyhydroxyvitamin D3 attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy.Biochem. Biophys. Res. Commun.2014451114214710.1016/j.bbrc.2014.07.08125078626
     [Google Scholar]
  25. WangJ. Beclin 1 bridges autophagy, apoptosis and differentiation.Autophagy20084794794810.4161/auto.678718769161
     [Google Scholar]
  26. UbertiF. LattuadaD. MorsanutoV. NavaU. BolisG. VaccaG. SquarzantiD.F. CisariC. MolinariC. Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways.J. Clin. Endocrinol. Metab.20149941367137410.1210/jc.2013‑210324285680
     [Google Scholar]
  27. GilaniS.J. Bin-JumahM.N. NadeemM.S. KazmiI. Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy.Expert Rev. Anti Infect. Ther.202220223124110.1080/14787210.2021.194187134112047
     [Google Scholar]
  28. LeeC. Controversial effects of vitamin D and related genes on viral infections, pathogenesis, and treatment outcomes.Nutrients202012496210.3390/nu1204096232235600
     [Google Scholar]
  29. KhanA.H. NasirN. NasirN. MahaQ. RehmanR. Vitamin D and COVID-19: Is there a role?J. Diabetes Metab. Disord.202120193193810.1007/s40200‑021‑00775‑633816359
     [Google Scholar]
  30. PengM.Y. LiuW.C. ZhengJ.Q. LuC.L. HouY.C. ZhengC.M. SongJ.Y. LuK.C. ChaoY.C. Immunological aspects of SARS-CoV-2 infection and the putative beneficial role of vitamin D.Int. J. Mol. Sci.20212210525110.3390/ijms2210525134065735
     [Google Scholar]
  31. Centers for Disease Control and Prevention CDC Museum COVID-19 Timeline. Available from: https://www.cdc.gov/museum/timeline/covid19.html
  32. World Health Organization COVID-19 Cases, World.2024Available from: https://data.who.int/dashboards/covid19/cases?n=c
  33. HuB. HuangS. YinL. The cytokine storm and COVID-19.J. Med. Virol.202193125025610.1002/jmv.2623232592501
     [Google Scholar]
  34. V’kovskiP. KratzelA. SteinerS. StalderH. ThielV. Coronavirus biology and replication: Implications for SARS-CoV-2.Nat. Rev. Microbiol.202119315517010.1038/s41579‑020‑00468‑633116300
     [Google Scholar]
  35. HuangC. WangY. LiX. RenL. ZhaoJ. HuY. ZhangL. FanG. XuJ. GuX. ChengZ. YuT. XiaJ. WeiY. WuW. XieX. YinW. LiH. LiuM. XiaoY. GaoH. GuoL. XieJ. WangG. JiangR. GaoZ. JinQ. WangJ. CaoB. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet20203951022349750610.1016/S0140‑6736(20)30183‑531986264
     [Google Scholar]
  36. WölfelR. CormanV.M. GuggemosW. SeilmaierM. ZangeS. MüllerM.A. NiemeyerD. JonesT.C. VollmarP. RotheC. HoelscherM. BleickerT. BrüninkS. SchneiderJ. EhmannR. ZwirglmaierK. DrostenC. WendtnerC. Virological assessment of hospitalized patients with COVID-2019.Nature2020581780946546910.1038/s41586‑020‑2196‑x32235945
     [Google Scholar]
  37. XuZ. ShiL. WangY. ZhangJ. HuangL. ZhangC. LiuS. ZhaoP. LiuH. ZhuL. TaiY. BaiC. GaoT. SongJ. XiaP. DongJ. ZhaoJ. WangF.S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome.Lancet Respir. Med.20208442042210.1016/S2213‑2600(20)30076‑X32085846
     [Google Scholar]
  38. GuanW. NiZ. HuY. LiangW. OuC. HeJ. LiuL. ShanH. LeiC. HuiD.S.C. DuB. LiL. ZengG. YuenK.Y. ChenR. TangC. WangT. ChenP. XiangJ. LiS. WangJ. LiangZ. PengY. WeiL. LiuY. HuY. PengP. WangJ. LiuJ. ChenZ. LiG. ZhengZ. QiuS. LuoJ. YeC. ZhuS. ZhongN. China Medical Treatment Expert Group for Covid-19 Clinical characteristics of coronavirus disease 2019 in China.N. Engl. J. Med.2020382181708172010.1056/NEJMoa200203232109013
     [Google Scholar]
  39. CarfìA. BernabeiR. LandiF. Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19.JAMA2020324660360510.1001/jama.2020.1260332644129
     [Google Scholar]
  40. Lopez-LeonS. Wegman-OstroskyT. PerelmanC. SepulvedaR. RebolledoP.A. CuapioA. VillapolS. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis.Sci. Rep.20211111614410.1038/s41598‑021‑95565‑834373540
     [Google Scholar]
  41. ThompsonE.J. WilliamsD.M. WalkerA.J. MitchellR.E. NiedzwiedzC.L. YangT.C. HugginsC.F. KwongA.S.F. SilverwoodR.J. Di GessaG. BowyerR.C.E. NorthstoneK. HouB. GreenM.J. DodgeonB. DooresK.J. DuncanE.L. WilliamsF.M.K. WalkerA.J. MacKennaB. InglesbyP. RentschC.T. CurtisH.J. MortonC.E. MorleyJ. MehrkarA. BaconS. HickmanG. BatesC. CrokerR. EvansD. WardT. CockburnJ. DavyS. BhaskaranK. SchultzeA. WilliamsonE.J. HulmeW.J. McDonaldH.I. TomlinsonL. MathurR. EggoR.M. WingK. WongA.Y.S. ForbesH. TazareJ. ParryJ. HesterF. HarperS. DouglasI.J. EvansS.J.W. SmeethL. GoldacreB. SteptoeA. PorteousD.J. McEachanR.R.C. TomlinsonL. GoldacreB. PatalayP. PloubidisG.B. KatikireddiS.V. TillingK. RentschC.T. TimpsonN.J. ChaturvediN. StevesC.J. OpenSAFELY Collaborative Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records.Nat. Commun.2022131352810.1038/s41467‑022‑30836‑035764621
     [Google Scholar]
  42. BilezikianJ.P. BikleD. HewisonM. Lazaretti-CastroM. FormentiA.M. GuptaA. MadhavanM.V. NairN. BabalyanV. HutchingsN. NapoliN. AcciliD. BinkleyN. LandryD.W. GiustinaA. Mechanisms in endocrinology: Vitamin D and COVID-19.Eur. J. Endocrinol.20201835R133R14710.1530/EJE‑20‑066532755992
     [Google Scholar]
  43. NiW. YangX. YangD. BaoJ. LiR. XiaoY. HouC. WangH. LiuJ. YangD. XuY. CaoZ. GaoZ. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.Crit. Care202024142210.1186/s13054‑020‑03120‑032660650
     [Google Scholar]
  44. WeirE.K. ThenappanT. BhargavaM. ChenY. Does vitamin D deficiency increase the severity of COVID-19?Clin. Med. (Lond.)2020204e107e10810.7861/clinmed.2020‑030132503801
     [Google Scholar]
  45. di FilippoL. FraraS. NannipieriF. CotellessaA. LocatelliM. Rovere QueriniP. GiustinaA. Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors.J. Clin. Endocrinol. Metab.202310810e1106e111610.1210/clinem/dgad20737051747
     [Google Scholar]
  46. SulliA. GotelliE. CasabellaA. PaolinoS. PizzorniC. AlessandriE. GrossoM. FeroneD. SmithV. CutoloM. Vitamin D and lung outcomes in elderly COVID-19 patients.Nutrients202113371710.3390/nu1303071733668240
     [Google Scholar]
  47. TownsendL. DyerA.H. McCluskeyP. O’BrienK. DowdsJ. LairdE. BannanC. BourkeN.M. Ní CheallaighC. ByrneD.G. KennyR.A. Investigating the relationship between vitamin D and persistent symptoms following SARS-CoV-2 infection.Nutrients2021137243010.3390/nu1307243034371940
     [Google Scholar]
  48. BikleD.D. Vitamin D and long COVID: Is there a role in prevention or treatment?J. Clin. Endocrinol. Metab.20231091e430e43110.1210/clinem/dgad33837279939
     [Google Scholar]
  49. RaveendranA.V. MisraA. Post COVID-19 syndrome (“Long COVID”) and diabetes: Challenges in diagnosis and management.Diabetes Metab. Syndr.202115510223510.1016/j.dsx.2021.10223534384972
     [Google Scholar]
  50. PizziniA. AichnerM. SahanicS. BöhmA. EggerA. HoermannG. KurzK. WidmannG. Bellmann-WeilerR. WeissG. TancevskiI. SonnweberT. Löffler-RaggJ. Impact of vitamin D deficiency on COVID-19: A prospective analysis from the COVID registry.Nutrients2020129277510.3390/nu1209277532932831
     [Google Scholar]
  51. AgergaardJ. UllahammerW.M. GunstJ.D. ØstergaardL. Schiøttz-ChristensenB. Characteristics of a Danish post-COVID cohort referred for examination due to persistent symptoms six months after mild acute COVID-19.J. Clin. Med.20221124733810.3390/jcm1124733836555954
     [Google Scholar]
  52. ChenK.Y. LinC.K. ChenN.H. Effects of vitamin D and zinc deficiency in acute and long COVID syndrome.J. Trace Elem. Med. Biol.20238012727810.1016/j.jtemb.2023.12727837566973
     [Google Scholar]
  53. Mohamed HusseinA.A.R. GalalI. AminM.T. MoshnibA.A. MakhloufN.A. MakhloufH.A. Abd-ElaalH.K. KholiefK.M.S. Abdel TawabD.A. Kamal EldinK.A. AttiaA.M. OthmanA.E.A. ShahJ. AiashH. Prevalence of vitamin D deficiency among patients attending Post COVID-19 follow-up clinic: A cross-sectional study.Eur. Rev. Med. Pharmacol. Sci.20222683038304510.26355/eurrev_202204_2863535503606
     [Google Scholar]
  54. JevalikarG. MithalA. SinghA. SharmaR. FarooquiK.J. MahendruS. DewanA. BudhirajaS. Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19.Sci. Rep.2021111625810.1038/s41598‑021‑85809‑y33737631
     [Google Scholar]
  55. SinopoliA. SciurtiA. IsonneC. SantoroM.M. BaccoliniV. The efficacy of multivitamin, vitamin A, vitamin B, vitamin C, and vitamin D supplements in the prevention and management of COVID-19 and long-COVID: An updated systematic review and meta-analysis of randomized clinical trials.Nutrients2024169134510.3390/nu1609134538732592
     [Google Scholar]
  56. CharoenpornV. TungsukruthaiP. TeacharushatakitP. HanvivattanakulS. SriyakulK. SukprasertS. KamalashiranC. TungsukruthaiS. CharernboonT. Effects of an 8-week high-dose vitamin D supplementation on fatigue and neuropsychiatric manifestations in post- COVID syndrome: A randomized controlled trial.Psychiatry Clin. Neurosci.20247810pcn.1371610.1111/pcn.1371639072958
     [Google Scholar]
  57. YongS.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments.Infect. Dis. (Lond.)2021531073775410.1080/23744235.2021.192439734024217
     [Google Scholar]
  58. Sánchez-ZunoG.A. González-EstevezG. Matuz-FloresM.G. Macedo-OjedaG. Hernández-BelloJ. Mora-MoraJ.C. Pérez-GuerreroE.E. García-ChagollánM. Vega-MagañaN. Turrubiates-HernándezF.J. Machado-SulbaranA.C. Muñoz-ValleJ.F. Vitamin D levels in COVID-19 outpatients from Western Mexico: Clinical correlation and effect of its supplementation.J. Clin. Med.20211011237810.3390/jcm1011237834071293
     [Google Scholar]
  59. SabicoS. EnaniM.A. SheshahE. AljohaniN.J. AldisiD.A. AlotaibiN.H. AlshingettiN. AlomarS.Y. AlnaamiA.M. AmerO.E. HussainS.D. Al-DaghriN.M. Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate COVID-19: A randomized clinical trial.Nutrients2021137217010.3390/nu1307217034202578
     [Google Scholar]
  60. GönenM.S. AlaylıoğluM. DurcanE. ÖzdemirY. ŞahinS. KonukoğluD. NohutO.K. ÜrkmezS. KüçükeceB. Balkanİ.İ. KaraH.V. BörekçiŞ. ÖzkayaH. KutlubayZ. DikmenY. KeskindemirciY. KarrasS.N. AnnweilerC. Gezen-AkD. DursunE. Rapid and effective vitamin D supplementation may present better clinical outcomes in COVID-19 (SARS-CoV-2) patients by altering serum INOS1, IL1B, IFNg, cathelicidin-LL37, and ICAM1.Nutrients20211311404710.3390/nu1311404734836309
     [Google Scholar]
  61. RastogiA. BhansaliA. KhareN. SuriV. YaddanapudiN. SachdevaN. PuriG.D. MalhotraP. Short term, high-dose vitamin D supplementation for COVID-19 disease: A randomised, placebo-controlled, study (SHADE study).Postgrad. Med. J.2022981156879010.1136/postgradmedj‑2020‑13906533184146
     [Google Scholar]
  62. CastilloM. CostaL.M. BarriosJ.M. Alcalá DíazJ.F. López MirandaJ. BouillonR. Quesada GomezJ.M. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study.J. Steroid Biochem. Mol. Biol.202020310575110.1016/j.jsbmb.2020.10575132871238
     [Google Scholar]
  63. IsraelA. CicurelA. FeldhamerI. SternF. DrorY. GiveonS.M. GillisD. StrichD. LavieG. Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: A retrospective case–control study.Intern. Emerg. Med.20221741053106310.1007/s11739‑021‑02902‑w35000118
     [Google Scholar]
  64. MuraiI.H. FernandesA.L. SalesL.P. PintoA.J. GoesslerK.F. DuranC.S.C. SilvaC.B.R. FrancoA.S. MacedoM.B. DalmolinH.H.H. BaggioJ. BalbiG.G.M. ReisB.Z. AntonangeloL. CaparboV.F. GualanoB. PereiraR.M.R. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: A randomized clinical trial.JAMA2021325111053106010.1001/jama.2020.2684833595634
     [Google Scholar]
  65. Alcala-DiazJ.F. Limia-PerezL. Gomez-HuelgasR. Martin-EscalanteM.D. Cortes-RodriguezB. Zambrana-GarciaJ.L. Entrenas-CastilloM. Perez-CaballeroA.I. López-CarmonaM.D. Garcia-AlegriaJ. Lozano Rodríguez-MancheñoA. Arenas-de LarrivaM.S. Pérez-BelmonteL.M. JungreisI. BouillonR. Quesada-GomezJ.M. Lopez-MirandaJ. Calcifediol treatment and hospital mortality due to COVID-19: A cohort study.Nutrients2021136176010.3390/nu1306176034064175
     [Google Scholar]
  66. KaronovaT.L. ChernikovaA.T. GolovatyukK.A. BykovaE.S. GrantW.B. KalininaO.V. GrinevaE.N. ShlyakhtoE.V. Vitamin D intake may reduce SARS-CoV-2 infection morbidity in health care workers.Nutrients202214350510.3390/nu1403050535276863
     [Google Scholar]
  67. AnnweilerC. BeaudenonM. GautierJ. SimonR. DubéeV. GonsardJ. Parot-SchinkelE. AidoudA. AlbaretG. AnnweilerC. Audemard-VergerA. AsfarM. BarréJ. BerteauF. BertolettiG. BeuscartJ-B. BigotA. BoucherS. Botelho-NeversE. Bourdel-MarchassonI. BoureauA.S. BrangierA. BrouessardC. BureauM.L. CardinaudN. CarlesM. Castro-LionardK. CelarierT. ChapeletG. ChirioD. ClabéE. CodronP. CourjonJ. CuaÉ. Danet-LamasouM. DecorbezA. De La ChapelleM. DemonchyE. DesvauxE. D’HautefeuilleM. DubéeV. DuvalG. FougèreB. GassieP. GiroultN. GuérinO. HankardR. HouvetM. JobardS. LacoutC. LafargueA. Laubarie-MouretC. Le FlochM. Le GentilS. LléonartS. LoisonJ. MahieuR. MaillotF. MartinezL. MathieuM. MauclereA. MénagerP. MichelE. NguyenT.B. OrdonezR. OtekpoM. PichonV. PoitauF. PommierG. RabierV. RissoK. RivièreH. RouaudA. Roubaud-BaudronC. SaccoG. ScholastiqueF. Seronie-DoutriauxE. TchallaA. TrzepizurW. VandammeY-M. COVIT-TRIAL study group COVID-19 and high- dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial.Trials2020211103110.1186/s13063‑020‑04928‑533371905
     [Google Scholar]
  68. AnnweilerG. CorvaisierM. GautierJ. DubéeV. LegrandE. SaccoG. AnnweilerC. Vitamin D supplementation associated with better survival in hospitalized frail elderly COVID-19 patients: The GERIA-COVID quasi-experimental study.Nutrients20201211337710.3390/nu1211337733147894
     [Google Scholar]
  69. AnnweilerC. BeaudenonM. GautierJ. GonsardJ. BoucherS. ChapeletG. DarsonvalA. FougèreB. GuérinO. HouvetM. MénagerP. Roubaud-BaudronC. TchallaA. SouberbielleJ.C. RiouJ. Parot-SchinkelE. CélarierT. COVIT-TRIAL study group High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.PLoS Med.2022195e100399910.1371/journal.pmed.100399935639792
     [Google Scholar]
/content/journals/crmr/10.2174/011573398X377824250604041213
Loading
Illuminating the Role of Vitamin D in Long COVID: A Narrative Review of its Impact on Recovery, Immunity, and Beyond
Curr. Respir. Med. Rev. 21, 459 (2025); https://doi.org/10.2174/011573398X377824250604041213
/content/journals/crmr/10.2174/011573398X377824250604041213
/content/journals/crmr/10.2174/011573398X377824250604041213
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): COVID recovery; COVID-19; long COVID; post-COVID syndrome; vitamin D deficiency; vitamin D supplementation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test